Pharmaceutical Policy

GLP-1 Medication Shortage in Australia: Policy Failures, Access Inequity, and the Path to Reform

Australia's GLP-1 receptor agonist shortage exposes deep structural failures in medicines policy. This analysis examines the supply crisis, access inequities, the compounding pharmacy debate, and six concrete reforms needed to ensure equitable access to life-changing obesity and diabetes treatments.